The Medicare GLP-1 Bridge is a temporary federal demonstration program running from July 1, 2026, through December 31, 2027
Arun Sanyal, director of the Virginia Commonwealth University Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, said in a news release
That's where anti-inflammatory smoothies become your secret weapon
Lee's team found that over the three years of the study, GLP-1 prescriptions among people ages 12 to 25 jumped by more than 594% (equivalent to a nearly sevenfold rise)
Track multiple metrics beyond just scale weight to capture comprehensive progress or lack thereof
Regarding serious renal events, although the combination showed a lower incidence (1.4 vs 2.0 events per 1000 person-years), the confidence interval was wide (HR 0.67